Millipore in sale discussions with “potential bidders”
This article was originally published in Clinica
Executive Summary
Bioscience research tools developer Millipore has confirmed that it is pursuing strategic alternatives, adding fuel to rumours that Thermo Fisher is about to make a $6bn offer for the firm. Millipore (Billerica, Massachusetts) said that its board of directors was aiming to enhance shareholder value by seeking options such as the possible merger or sale of the company. Earlier this week, Millipore shares rocketed to their highest ever value in response to rumours of a takeover from Thermo (www.clinica.co.uk, February 24 2009).